Erythropoietin and Friedreich Ataxia: Time for a Reappraisal?
Friedreich ataxia (FRDA) is a rare neurological disorder due to deficiency of the mitochondrial protein frataxin. Frataxin deficiency results in impaired mitochondrial function and iron deposition in affected tissues. Erythropoietin (EPO) is a cytokine which was mostly known as a key regulator of er...
Main Authors: | Sylvia Boesch, Elisabetta Indelicato |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-04-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2019.00386/full |
Similar Items
-
Friedreichs ataxia in a diabetic patient
by: Inna Igorevna Klefortova, et al.
Published: (2010-06-01) -
ALTERATIONS OF MITOCHONDRIAL BIOGENESIS AND ALTERATIONS OF MITOCHONDRIAL ANTIOXIDANT DEFENSE IN FRIEDREICH’S ATAXIA
by: Marmolino, Daniele
Published: (2011) -
Inducible and reversible phenotypes in a novel mouse model of Friedreich’s Ataxia
by: Vijayendran Chandran, et al.
Published: (2017-12-01) -
Friedreich's Ataxia – A Clinical Diagnosis
by: Md. Fekarul Islam, et al.
Published: (2015-01-01) -
Dysregulation of cellular iron metabolism in Friedreich ataxia: from primary iron-sulfur cluster deficit to mitochondrial iron accumulation
by: Alain eMartelli, et al.
Published: (2014-06-01)